Metronomic Chemotherapy--A New Path to Treat Advanced Non-small Cell Lung Cancer - Wikidata - awgldk - TriplyDB

Metronomic Chemotherapy--A New Path to Treat Advanced Non-small Cell Lung Cancer

Metronomic Chemotherapy--A New Path to Treat Advanced Non-small Cell Lung Cancer

http://www.wikidata.org/entity/Q27015786

about

Metronomic Chemotherapy--A New Path to Treat Advanced Non-small Cell Lung Cancer

http://www.wikidata.org/entity/Q27015786

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Metronomic Chemotherapy--A New Path to Treat Advanced Non-small Cell Lung Cancer

@ast

Metronomic Chemotherapy--A New Path to Treat Advanced Non-small Cell Lung Cancer

@en

Metronomic Chemotherapy--A New Path to Treat Advanced Non-small Cell Lung Cancer

@nl

type

label

Metronomic Chemotherapy--A New Path to Treat Advanced Non-small Cell Lung Cancer

@ast

Metronomic Chemotherapy--A New Path to Treat Advanced Non-small Cell Lung Cancer

@en

Metronomic Chemotherapy--A New Path to Treat Advanced Non-small Cell Lung Cancer

@nl

prefLabel

Metronomic Chemotherapy--A New Path to Treat Advanced Non-small Cell Lung Cancer

@ast

Metronomic Chemotherapy--A New Path to Treat Advanced Non-small Cell Lung Cancer

@en

Metronomic Chemotherapy--A New Path to Treat Advanced Non-small Cell Lung Cancer

@nl

P1433

Q27015786-892B449C-A79E-45A7-A70A-EF568A4B74BE

P1476

Q27015786-083BF021-B5E5-402E-9BA7-9035D320D757

P2093

Q27015786-284AB4BE-E394-4816-BCC3-D72BD1F1812C

Q27015786-9F7F3677-B8EA-4485-8B4A-08676CCC3409

Q27015786-E450C1AF-52E3-4276-A0EA-00F7D1A882DF

P2860

Q27015786-001AD4BE-DA43-4461-957C-ED40CCFDE2EB

Q27015786-00E1E53D-9A3C-40DC-BFA5-2157C332145B

Q27015786-0BF1B8A9-F777-4CCF-A6C7-7FC5337F8616

Q27015786-0E1398E0-2A50-4D74-9A4E-5C5DC6977401

Q27015786-175CB84D-096F-4DD5-BD0F-3F6FC2445C0F

Q27015786-1F88FFEF-9F9E-4C83-BE6E-98F3C46EE81A

Q27015786-24AA5EC6-7084-442E-B0FC-A428EDB028ED

Q27015786-29E1982B-EAB2-4C50-954E-80ADDF210BB1

Q27015786-3A3C7F5D-AAAD-4B7A-9392-FBA70EFC676E

Q27015786-3F56711C-E368-4A53-9B0A-5CEE5F8449C0

P304

Q27015786-F201D961-D6AA-4061-9C33-4A6B5A33FB36

P31

Q27015786-9BDC9DC6-37C4-42BA-928B-705875A882BB

P356

Q27015786-58C1EC7E-5CE0-44D4-B2B9-ADBA7F50C56C

P433

Q27015786-464443A6-241F-4D93-8AA5-7BB33E35635A

P478

Q27015786-7D3559BD-FE23-4EBA-9405-4C7C56BD46BD

P577

Q27015786-40BDA427-2FCD-47D6-9600-F2ABFB3FF136

P698

Q27015786-DA57E4C2-AB7B-411C-A110-8F64643577DB

P921

Q27015786-CFBDED09-2987-44F3-9865-67C9D8A66027

P932

Q27015786-82B8AB48-4196-4F68-8DD4-7F98E872917C

P356

J.ISSN.1009-3419.2015.04.08

P1433

Zhongguo fei ai za zhi

P1476

Metronomic Chemotherapy--A New Path to Treat Advanced Non-small Cell Lung Cancer

@en

P2093

Jingjing Liu

http://www.w3.org/2001/XMLSchema#string

Shuang Zhang

http://www.w3.org/2001/XMLSchema#string

Ying Cheng

http://www.w3.org/2001/XMLSchema#string

P2860

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

Second-Line Therapy for Advanced NSCLC

Metronomic chemotherapy: an attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer

Drug-tolerant cancer cells show reduced tumor-initiating capacity: depletion of CD44 cells and evidence for epigenetic mechanisms

Tumorigenesis and the angiogenic switch

Cyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivo.

T-cell immunity in the induction and maintenance of a tumour dormant state.

Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice

The combination of a low-dose chemotherapeutic agent, 5-fluorouracil, and an adenoviral tumor vaccine has a synergistic benefit on survival in a tumor model system.

P304

232-239

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3779/J.ISSN.1009-3419.2015.04.08

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25936888

http://www.w3.org/2001/XMLSchema#string

P921

P932

6000289

http://www.w3.org/2001/XMLSchema#string